<code id='748444CDEB'></code><style id='748444CDEB'></style>
    • <acronym id='748444CDEB'></acronym>
      <center id='748444CDEB'><center id='748444CDEB'><tfoot id='748444CDEB'></tfoot></center><abbr id='748444CDEB'><dir id='748444CDEB'><tfoot id='748444CDEB'></tfoot><noframes id='748444CDEB'>

    • <optgroup id='748444CDEB'><strike id='748444CDEB'><sup id='748444CDEB'></sup></strike><code id='748444CDEB'></code></optgroup>
        1. <b id='748444CDEB'><label id='748444CDEB'><select id='748444CDEB'><dt id='748444CDEB'><span id='748444CDEB'></span></dt></select></label></b><u id='748444CDEB'></u>
          <i id='748444CDEB'><strike id='748444CDEB'><tt id='748444CDEB'><pre id='748444CDEB'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:leisure time    Page View:5676
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          A new approach to psychiatric drug development
          A new approach to psychiatric drug development

          AdobeInmanyways,psychiatryisstillflyingblind.Peopleexperiencingmentalhealthconditionsareprescribedva

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          Senate bill would ban some hospital facility fees

          Sen.BernieSanders(I-Vt.)andaRepublicancolleagueintroducedmeasurestoreformhospitalcontractingandbanso